Skip to main content

Table 2 Comparison of treatment between clamp and control groups

From: The new clinical application of bilateral-contralateral cervix clamp in postpartum hemorrhage: a retrospective cohort study

 

Clamp group

(n = 22)

Control group

(n = 25)

P value

Bleeding in labor (n = 27)

(n = 12)

(n = 15)

 

 Intrapartum blood loss (g), mean (SD)

656.2±72.79

811.8±86.07

.001a

Bleeding in the ward (n = 20)

(n = 10)

(n= 10)

 

 Blood loss in 30 min (g), mean (SD)

42.8±6.60

126.3±86.97

.007a

 Blood loss in 30~60 min (g), mean (SD)

10.4±1.96

21.88±2.30

.000a

Hemoglobin (g/L),mean (SD)

 Preoperative Hb

119±4.10

121.4±4.19

.058

 Postoperative Hb

96.9±8.33

96.1±7.39

.718

Blood transfusion, n(%)

2 (9.1%)

3 (12%)

.746

Repeated usage of uterotonic, n(%)

  

.001a

 ≤2 (type/time)

18 (81.8%)

9 (36%)

 

 ≥3 (type/time)

4 (18.2%)

16 (64%)

 

Uterotonic side effect, n(%)

4 (18.2%)

12 (48%)

.031a

Clamp complications, n(%)

0

 

Surgical procedures, n(%)

 Intrauterine Bakri balloon

1 (4.5%)

3 (12%)

.36a

 Urgent UAE

1 (4.5%)

1 (4.0%)

.93a

 Laparotomy

0

0

Hospital stay (days), mean (SD)

4.1±1.57

3.8±1.61

.535

  1. Abbreviations: Hb Hemoglobin, UAE Uterine artery embolization, SD Standard deviation; a Denotes significant values if p < 0.05